Bioimpedance Spectroscopy Monitoring Reduces Long-term Clinical Lymphedema Risk
The Kaplan–Meier analysis shows that patients with early detection using L-Dex and intervention have statistically significant higher rates of lymphedema progression free survival through three years compared to using tape measure. This reinforces the importance of monitoring patients for three years, since progression to chronic lymphedema occurred throughout the three-year follow up period.
Boyages J, Vicini F, Shah C. Icon Cancer Care; GenesisCare; Cleveland Clinic
Bioimpedance Spectroscopy Monitoring Reduces Long-term Clinical Lymphedema Risk
The Kaplan–Meier analysis shows that patients with early detection using L-Dex and intervention have statistically significant higher rates of lymphedema progression free survival through three years compared to using tape measure. This reinforces the importance of monitoring patients for three years, since progression to chronic lymphedema occurred throughout the three-year follow up period.
Open access: Yes
View